Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. They are developing first- in-class cell therapy products based on the notion that their body contains finely tuned mechanisms for self-repair. Their technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication.